NOVT

+ Watchlist + Portfolio

Novanta Inc.

Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $143.58
52-Week Range: $98.27 – $176.38
Market Cap: $5.65B
P/E (TTM): 94.47
EPS (TTM): 1.58
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 3.49
PEG Ratio: —
Return on Equity: 5.11%
Return on Assets: 4.09%
Gross Margin: 44.54%
Operating Margin: 11.50%
Profit Margin: 6.00%
Current Ratio: 4.57
Debt/Equity: 0.18
Total Debt: $285.60M
Free Cash Flow: $118.38M
Revenue Growth: 10.30%
Earnings Growth: 150.00%
Enterprise Value: $5.21B

NOVT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$860.90M	$881.66M	$949.25M	$980.60M
Cost of Revenue	$482.43M	$481.76M	$527.70M	$545.32M
Gross Profit	$378.47M	$399.90M	$421.55M	$435.28M
Research & Development	$85.77M	$91.68M	$95.52M	$95.48M
Selling, General & Admin	$158.90M	$164.46M	$175.94M	$195.66M
Operating Expenses	$271.01M	$276.59M	$297.25M	$318.62M
Operating Income	$107.46M	$123.31M	$124.29M	$116.66M
EBITDA	$160.62M	$169.92M	$179.86M	$178.60M
Pretax Income	$87.16M	$83.75M	$79.07M	$69.64M
Income Tax	$13.11M	$10.87M	$14.98M	$15.81M
Net Income	$74.05M	$72.88M	$64.09M	$53.83M
Diluted EPS	2.06	2.02	1.77	1.47
Diluted Shares	35.91M	36.03M	36.12M	36.70M

NOVT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$100.11M	$105.05M	$113.99M	$380.87M
Receivables	$139.21M	$147.51M	$159.10M	$194.26M
Inventory	$168.00M	$149.37M	$144.61M	$188.28M
Current Assets	$420.52M	$415.30M	$433.65M	$782.60M
Total Assets	$1.24B	$1.23B	$1.39B	$1.81B
Current Liabilities	$164.52M	$139.18M	$167.79M	$212.37M
Long-Term Debt	$430.66M	$349.40M	$411.95M	$212.54M
Total Debt	$489.38M	$404.56M	$470.24M	$301.91M
Total Liabilities	$663.63M	$552.60M	$642.81M	$492.82M
Retained Earnings	$130.58M	$203.46M	$267.55M	$321.38M
Shareholders' Equity	$577.59M	$673.46M	$745.70M	$1.31B
Working Capital	$256.00M	$276.12M	$265.86M	$570.23M
Net Debt	$335.36M	$249.32M	$302.65M	—

NOVT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$90.78M	$120.08M	$158.51M	$64.06M
Capital Expenditure	-$21.11M	-$19.96M	-$17.16M	-$15.63M
Free Cash Flow	$69.67M	$100.11M	$141.35M	$48.43M
Depreciation & Amortisation	$53.16M	$46.61M	$55.56M	$61.93M
Stock-Based Compensation	$23.11M	$25.59M	$23.31M	$29.54M
Investing Cash Flow	-$42.54M	-$19.89M	-$208.19M	-$74.32M
Financing Cash Flow	-$60.15M	-$97.85M	$56.94M	$276.33M
Share Repurchases	-$10.00M	$0.00	$0.00	-$39.28M
Net Change in Cash	-$11.92M	$2.33M	$7.27M	$266.06M

NOVT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$233.37M	$241.05M	$247.84M	$258.35M	$257.71M	$265.81M
Cost of Revenue	$129.01M	$134.30M	$136.91M	$145.09M	$144.13M	$144.89M
Gross Profit	$104.35M	$106.75M	$110.92M	$113.26M	$113.58M	$120.92M
Research & Development	$23.24M	$25.29M	$24.09M	$22.87M	$23.25M	$23.97M
Selling, General & Admin	$45.60M	$47.10M	$51.38M	$51.58M	$54.41M	$59.97M
Operating Expenses	$74.39M	$79.26M	$82.40M	$82.57M	$83.43M	$90.36M
Operating Income	$29.97M	$27.48M	$28.52M	$30.69M	$30.14M	$30.56M
EBITDA	$43.53M	$43.06M	$44.24M	$47.77M	$44.30M	$45.21M
Pretax Income	$26.42M	$5.79M	$15.76M	$21.68M	$26.35M	$15.90M
Income Tax	$5.21M	$1.29M	$5.11M	$4.21M	$5.25M	$3.36M
Net Income	$21.21M	$4.50M	$10.65M	$17.47M	$21.10M	$12.54M
Diluted EPS	0.59	0.12	0.30	0.45	0.51	0.30
Diluted Shares	36.13M	36.08M	36.04M	38.68M	41.16M	41.16M

NOVT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$106.05M	$109.91M	$89.22M	$380.87M	$388.80M	$718.65M
Receivables	$170.03M	$169.36M	$180.32M	$194.26M	$182.69M	$191.54M
Inventory	$145.44M	$168.06M	$179.98M	$188.28M	$193.14M	$192.71M
Current Assets	$434.14M	$462.10M	$468.42M	$782.60M	$786.80M	$1.12B
Total Assets	$1.39B	$1.51B	$1.51B	$1.81B	$1.80B	$2.14B
Current Liabilities	$146.69M	$181.94M	$186.86M	$212.37M	$220.79M	$245.88M
Long-Term Debt	$385.28M	$454.04M	$445.66M	$212.54M	$201.00M	$188.16M
Total Debt	$442.53M	$513.41M	$504.48M	$301.91M	$290.49M	$284.72M
Total Liabilities	$615.70M	$709.62M	$704.34M	$492.82M	$488.03M	$523.11M
Retained Earnings	$288.76M	$293.25M	$303.91M	$321.38M	$342.48M	$355.02M
Shareholders' Equity	$769.75M	$801.45M	$801.48M	$1.31B	$1.31B	$1.62B
Working Capital	$287.45M	$280.16M	$281.56M	$570.23M	$566.01M	$877.65M
Net Debt	$284.09M	$349.33M	$362.12M	—	—	—

NOVT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$31.68M	$15.07M	$8.49M	$8.80M	$51.61M	$64.93M
Capital Expenditure	-$4.28M	-$3.39M	-$4.28M	-$3.67M	-$4.14M	-$7.47M
Free Cash Flow	$27.40M	$11.68M	$4.21M	$5.13M	$47.47M	$57.47M
Depreciation & Amortisation	$13.56M	$15.58M	$15.71M	$17.08M	$14.16M	$14.65M
Stock-Based Compensation	$7.10M	$7.50M	$6.70M	$8.24M	$9.80M	$9.84M
Investing Cash Flow	$1.25M	-$66.56M	-$5.40M	-$3.61M	-$3.79M	-$7.47M
Financing Cash Flow	-$42.73M	$54.83M	-$23.42M	$287.65M	-$40.12M	$270.60M
Share Repurchases	-$6.16M	$0.00	-$14.06M	-$19.07M	-$18.64M	$0.00
Net Change in Cash	-$9.79M	$3.34M	-$20.33M	$292.84M	$7.69M	$328.06M

Market Snapshot

About

Novanta supplies precision photonics, vision, and motion control technology for medical equipment manufacturers and advanced industrial original equipment manufacturers.